Calmare Therapeutics (OTCMKTS:CTTC) and AtriCure (NASDAQ:ATRC) Critical Analysis
AtriCure (NASDAQ:ATRC – Get Free Report) and Calmare Therapeutics (OTCMKTS:CTTC – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of current ratings […]
More Stories
Greif, Inc. (NYSE:GEF) Short Interest Update
Greif, Inc. (NYSE:GEF – Get Free Report) was the recipient of a significant growth in short interest during the month...
Short Interest in First Commonwealth Financial Co. (NYSE:FCF) Declines By 10.4%
First Commonwealth Financial Co. (NYSE:FCF – Get Free Report) saw a large drop in short interest in October. As of...
Critical Contrast: SuRo Capital (NASDAQ:SSSS) and Ellsworth Growth and Income Fund (NYSE:ECF)
Ellsworth Growth and Income Fund (NYSE:ECF – Get Free Report) and SuRo Capital (NASDAQ:SSSS – Get Free Report) are both...
Short Interest in Greenpro Capital Corp. (NASDAQ:GRNQ) Drops By 14.9%
Greenpro Capital Corp. (NASDAQ:GRNQ – Get Free Report) was the target of a large decline in short interest in October....
GH Research PLC (NASDAQ:GHRS) Short Interest Up 7.3% in October
GH Research PLC (NASDAQ:GHRS – Get Free Report) was the recipient of a large growth in short interest during the...
Yamaguchi Financial Group (OTCMKTS:YFGSF) Reaches New 52-Week Low – Should You Sell?
Yamaguchi Financial Group, Inc. (OTCMKTS:YFGSF – Get Free Report)’s share price hit a new 52-week low during mid-day trading on...